Darzalex® (daratumumab), Kyprolis® (carfilzomib) – Expanded indication
August 20, 2020 - FDA approved the combination use of Janssen’s Darzalex (daratumumab) with Amgen’s Kyprolis (carfilzomib) and dexamethasone in adult patients with relapsed or refractory multiple myeloma who have received one to three prior lines of therapy.
Top